127 related articles for article (PubMed ID: 33161259)
21. Socioeconomic Status, Not Race, Is Associated With Reduced Survival in Esophagectomy Patients.
Erhunmwunsee L; Gulack BC; Rushing C; Niedzwiecki D; Berry MF; Hartwig MG
Ann Thorac Surg; 2017 Jul; 104(1):234-244. PubMed ID: 28410639
[TBL] [Abstract][Full Text] [Related]
22. Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy.
Caparrotti F; O'Sullivan B; Bratman SV; Ringash J; Lu L; Bayley A; Cho J; Giuliani M; Hope A; Kim J; Waldron J; Hansen A; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Song Y; Xu W; Huang SH
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):858-867. PubMed ID: 28258893
[TBL] [Abstract][Full Text] [Related]
23. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
[TBL] [Abstract][Full Text] [Related]
24. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
[TBL] [Abstract][Full Text] [Related]
25. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
27. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus in oropharyngeal squamous cell carcinomas in Korea: use of G1 cycle markers as new prognosticators.
Park WS; Ryu J; Cho KH; Choi MK; Moon SH; Yun T; Chun BS; Lee GK; Ahn HJ; Lee JH; Vermeer P; Jung YS
Head Neck; 2012 Oct; 34(10):1408-17. PubMed ID: 22052559
[TBL] [Abstract][Full Text] [Related]
29. C-reactive Protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer.
Johnson-Obaseki S; Caulley L; Corsten M; Liu G; Dimitroulakos J; Goldstein D; Irish J; Rider J
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):494-501. PubMed ID: 30226795
[TBL] [Abstract][Full Text] [Related]
30. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
31. Smoking cessation is associated with improved survival in oropharynx cancer treated by chemoradiation.
Platek AJ; Jayaprakash V; Merzianu M; Platek ME; Cohan DM; Hicks WL; Marimuthu SP; Winslow TB; Gupta V; Arshad H; Kuriakose MA; Dibaj S; Marshall JR; Reid ME; Warren GW; Singh AK
Laryngoscope; 2016 Dec; 126(12):2733-2738. PubMed ID: 27346612
[TBL] [Abstract][Full Text] [Related]
32. Clinical Significance of Sarcopenia among Patients with Advanced Oropharyngeal Cancer.
Tamaki A; Manzoor NF; Babajanian E; Ascha M; Rezaee R; Zender CA
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):480-487. PubMed ID: 30105922
[TBL] [Abstract][Full Text] [Related]
33. Racial disparities in tumor features and outcomes of patients with squamous cell carcinoma of the tonsil.
Albert A; Giri S; Kanakamedala M; Mangana S; Bhanat E; Shenoy V; Thomas TV; Joseph S; Gonzalez M; Shalaby A; Vijayakumar S
Laryngoscope; 2019 Mar; 129(3):643-654. PubMed ID: 30152118
[TBL] [Abstract][Full Text] [Related]
34. Comorbidity and prognosis in head and neck cancers: Differences by subsite, stage, and human papillomavirus status.
Habbous S; Harland LT; La Delfa A; Fadhel E; Xu W; Liu FF; Goldstein D; Waldron J; Huang SH; O'Sullivan B; Liu G
Head Neck; 2014 Jun; 36(6):802-10. PubMed ID: 23616414
[TBL] [Abstract][Full Text] [Related]
35. Human Papilloma Virus-positive Oropharyngeal Squamous Cell Carcinoma in the Elderly.
Dave E; Su W; Gupta V; Miles B; Demicco E; Soriano T; Bakst RL
Anticancer Res; 2017 Apr; 37(4):1847-1851. PubMed ID: 28373450
[TBL] [Abstract][Full Text] [Related]
36. Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.
Liskamp CP; Janssens GO; Bussink J; Melchers WJ; Kaanders JH; Verhoef CG
Head Neck; 2016 Dec; 38(12):1780-1787. PubMed ID: 27248701
[TBL] [Abstract][Full Text] [Related]
37. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
[TBL] [Abstract][Full Text] [Related]
38. Effect of HPV Status on Survival of Oropharynx Cancer with Distant Metastasis.
Kaplon AW; Galloway TJ; Bhayani MK; Liu JC
Otolaryngol Head Neck Surg; 2020 Aug; 163(2):372-374. PubMed ID: 32204640
[TBL] [Abstract][Full Text] [Related]
39. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
40. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]